Such risks include , but are not limited to , the risk of whether certain market segments grow as anticipated ; clinical trial results ; the competitive environment in the biotechnology industry ; and whether the Anesiva can successfully develop new products and the degree to which these gain market acceptance as well as other risks detailed from time to time in Anesiva 's filings with the Securities and Exchange Commission ( the " SEC " ) , including Anesiva 's most recent Annual Report on Form 10-K for the fiscal year ended December 31 , 2008 , its Quarterly Reports on Form 10-Q and its Current Reports on Form 8-K as filed with the SEC .